A combined superiority and non-inferiority approach to multiple endpoints in clinical trials

被引:17
|
作者
Bloch, Daniel A. [1 ]
Lai, Tze Leung
Su, Zheng
Tubert-Bitter, Pascale
机构
[1] Stanford Univ, Dept Hlth Res & Policy, Div Biostat, HRP Biostat, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Stat, Stanford, CA 94305 USA
[3] INSERM, U 472, F-94807 Villejuif, France
关键词
bootstrap tests; efficacy and toxicity; multivariate outcomes; non-inferiority; superiority;
D O I
10.1002/sim.2611
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Treatment comparisons in clinical trials often involve multiple endpoints. By making use of bootstrap tests, we develop a new non-parametric approach to multiple-endpoint testing that can be used to demonstrate non-inferiority of a new treatment for all endpoints and superiority for some endpoint when it is compared to an active control. It is shown that this approach does not incur a large multiplicity cost in sample size to achieve reasonable power and that it can incorporate complex dependencies in the multivariate distributions of all outcome variables for the two treatments via bootstrap resampling. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:1193 / 1207
页数:15
相关论文
共 50 条
  • [21] Correction to: Methodological aspects of superiority, equivalence, and non-inferiority trials
    Stefanos Roumeliotis
    Graziella D’Arrigo
    Giovanni Tripepi
    [J]. Internal and Emergency Medicine, 2021, 16 : 247 - 247
  • [22] Surrogate endpoints and non-inferiority trials in chronic viral hepatitis
    Gentile, Ivan
    Borgia, Guglielmo
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 (05) : 778 - 778
  • [23] A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes
    Hirotsu, Chihiro
    [J]. PHARMACEUTICAL STATISTICS, 2007, 6 (03) : 193 - 203
  • [24] IS THERE A CONSENSUS REGARDING CLINICALLY RELEVANT NON-INFERIORITY MARGINS USED FOR KEY ONCOLOGY ENDPOINTS IN NON-INFERIORITY ONCOLOGY TRIALS?
    Hashim, M.
    He, J.
    Hu, P.
    Soikkeli, F.
    Gebregergish, S.
    Heeg, B.
    Lam, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S228 - S228
  • [25] Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials
    Wang, SJ
    Hung, HMJ
    Tsong, Y
    Cui, L
    [J]. STATISTICS IN MEDICINE, 2001, 20 (13) : 1903 - 1912
  • [26] Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
    Tang, Nian-Sheng
    Yu, Bin
    Tang, Man-Lai
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2014, 14
  • [27] Blinded sample size reestimation in non-inferiority trials with binary Endpoints
    Friede, Tim
    Mitchell, Charles
    Mueller-Velten, Guenther
    [J]. BIOMETRICAL JOURNAL, 2007, 49 (06) : 903 - 916
  • [28] Statistical Notes. Randomized controlled clinical trials of superiority and non-inferiority: critical considerations
    Marubini, Ettore
    Rebora, Paola
    Reina, Giuseppe
    [J]. GIORNALE ITALIANO DI CARDIOLOGIA, 2005, 6 (06) : 361 - 364
  • [29] Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
    Nian-Sheng Tang
    Bin Yu
    Man-Lai Tang
    [J]. BMC Medical Research Methodology, 14
  • [30] Non-Inferiority Trials
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1355): : 1 - 1